[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation].
Fujii F, Terao T, Nishimori H, Fujii K, Matsuo T, Yoshino T, Ueda H, Oyama T, Matsumura A, Kondo K, Matsubara C, Fujiwara K, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y.
Fujii F, et al. Among authors: maeda y.
Rinsho Ketsueki. 2024;65(7):622-627. doi: 10.11406/rinketsu.65.622.
Rinsho Ketsueki. 2024.
PMID: 39098011
Japanese.